Michael Gennett is a health care regulatory attorney with 25 years of experience representing health care providers, and 16 of those years as a health care law specialist certified by the Florida Bar. He focuses his practice on state licensing, Medicare and Medicaid compliance, HIPAA and other regulatory issues. He represents health care clinicians and companies, including medical practices, medical equipment companies, pharmacies and home health agencies. Michael has successfully defended health care providers in Medicare and Medicaid overpayment appeals, investigations and other program integrity efforts by government contractors. In addition, he has worked on False Claims Act whistleblower cases and data breaches. He counsels clients on a variety of business issues, including:

  • Drafting contractual arrangements to meet client business needs
  • Defending licensees against state prosecutions
  • Mergers and acquisitions
  • Fraud and abuse compliance
  • HIPAA privacy and security regulations
  • Regulated state law requirements

Michael served as a past chair of The Florida Bar’s Health Law Certification Committee, a board that oversees the examination process for certifying attorneys as health law specialists. He is currently a member of The Florida Bar Health Law Executive Council, and is Chair of the Health Law Continuing Legal Education Committee.

Education

  • St. Thomas University School of Law (J.D., 1996)
    • Florida State University (B.S., 1985)

      Bar Admission

      • Florida, 1996

      Court Admissions

      • U.S. District Court, Southern District of Florida

      Professional Affiliations

      • The Florida Bar, Health Law Section 
        • Secretary
        • Executive Council and CLE Section Chair
      • Ann Storck Center, Board Member
      • Florida Association of Medical Equipment Services, Board Member
      • American Health Lawyers Association, Member
      • Special Olympics Miami-Dade, Executive Committee, Board Member
      • Victory Living Programs, Board Member

      Recognition

      • Ranked in Chambers USA: America’s Leading Lawyers for Business, Healthcare, Florida, 2024-2025
      • Board Certified in Health Law since 2004, The Florida Bar Board of Legal Specialization and Education
      • Selected for inclusion in Best Lawyers in America® for:
        • Administrative / Regulatory Law, 2025
        • Health Care Law, 2013-2026
      • Chair of the Florida Bar Health Law Section Mentorship Program
      • Speaker at Zone Program Integrity Contract Issues, 2017 Home Care Association of Florida Annual Conference, Orlando, Florida
      • South Florida Business Journal, Recognized as a “Heavy Hitter in Health Care”
      • Speaker at Federal Self-Referral Laws, Florida Bar CLE on Advanced Topics in Healthcare Law, March 2017, Orlando, Florida
      Publications
      All Publications
      Moratorium on New DME Medicaid Provider Enrollment in Florida
      Key Takeaways: Florida’s Agency for Healthcare Administration (AHCA) has implemented a six-month moratorium on the enrollment of new Durable Medical Equipment (DME) providers, effective March 20, 2026. The moratorium applies statewide and affects all new DME provider applications submitted after the effective date. Applications submitted prior to March 20 will continue to be processed. Pharmacies, hospitals and providers furnishing DME as a secondary service are not subject to the moratorium and may continue with enrollment. This action follows a similar federal moratorium from the Centers for Medicare & Medicaid Services (CMS) aimed at curbing fraud and protecting taxpayer resources, as Florida has been identified as a high-risk area for DME-related fraud. Effective March 20, 2026, Florida’s AHCA has implemented a statewide moratorium on the enrollment
      Read More
      Buyer Beware - New Restrictions on the Purchase and Sale of Medical Equipment Companies
      Durable Medical Equipment (DME) owners and prospective purchasers need to be aware of a new Medicare rule that significantly restricts the transfer of ownership in these types of companies. Failure to be aware of the new restriction could result in a buyer ending up with a company that cannot bill Medicare. Worse, attorneys and brokers involved in the deal could end up with egg on their faces for not being aware of the restriction. Historically, a change in stock ownership of a Medicare-enrolled DME only requires that the parties to a transaction complete a CMS 855S form advising CMS of the changes in stock ownership. The Medicare provider number remains the same and there is no down-time in the DME’s ability
      Read More